首页> 外文学位 >Sleep Disruption Among Cancer Patients Following Autologous Hematopoietic Stem Cell Transplantation
【24h】

Sleep Disruption Among Cancer Patients Following Autologous Hematopoietic Stem Cell Transplantation

机译:自体造血干细胞移植后癌症患者的睡眠中断

获取原文
获取原文并翻译 | 示例

摘要

Background: Sleep disruption is one of the most commonly reported quality of life concerns among cancer patients who have undergone hematopoietic stem cell transplantation (HSCT). Despite the high percentage of patients reporting sleep concerns, relatively little research has characterized sleep problems or explored relationships with psychological factors. In addition, no studies have used actigraph technology to characterize sleep issues among transplant recipients.;Method: Autologous HSCT recipients who were 6 to 18 months post-transplant were invited to participate. Patients completed self-report measures of cancer-related distress, fear of cancer recurrence, dysfunctional cognitions about sleep, and maladaptive sleep behaviors upon enrollment, wore an actigraph and completed a sleep log at home for 7 days, and completed a self-report measure of sleep disruption on day 7 of the study.;Results: 84 autologous HSCT recipients (age M = 60, 45% female) were enrolled and provided complete data. Forty-one percent of patients met criteria for sub-clinical or clinical insomnia based on patient self-report. Examination of actigraph data indicated that certain aspects of sleep were poorer than others (wake after sleep onset M = 66 minutes; total sleep time M = 6.5 hours; sleep efficiency M = 78%; sleep onset latency M = 21 minutes). Measures of cancer-related distress, fear of cancer recurrence, cognitive distortions, and maladaptive behavioral patterns were related to subjectively reported sleep disruption, p's < .05, but were not related to objectively measured sleep disruption. Further examination revealed that the cognitive and behavioral factors accounted for the largest unique variance in subjectively reported sleep disruption.;Conclusion: Results from the present study suggest that many HSCT recipients continue to experience sleep disruption during the survivorship period following transplant. Cancer-specific factors, dysfunctional cognitions about sleep, and maladaptive sleep behaviors were related to self-reported sleep disruption and are ripe targets for a cognitive behavioral intervention.
机译:背景:睡眠中断是接受造血干细胞移植(HSCT)的癌症患者中最普遍报告的生活质量问题之一。尽管报告睡眠问题的患者比例很高,但相对较少的研究已将睡眠问题或与心理因素的关系作为特征。此外,还没有研究使用活动记录仪技术来表征移植受者的睡眠问题。方法:邀请移植后6至18个月的自体HSCT接受者参加。患者完成自我报告的癌症相关困扰,对癌症复发的恐惧,对睡眠的认知障碍以及入选时的不良适应性睡眠行为的自我报告测量,戴着电笔并在家中完成7天的睡眠日志,并完成自我报告测量结果:在研究的第7天睡眠中断。结果:招募了84位自体HSCT接受者(M = 60,女性45%),并提供了完整的数据。根据患者自我报告,有41%的患者达到了亚临床或临床失眠的标准。人体活动记录仪数据的检查表明,某些方面的睡眠较其他方面差(入睡后M = 66分钟;总入睡时间M = 6.5小时;睡眠效率M = 78%;入睡潜伏期M = 21分钟)。癌症相关困扰,对癌症复发的恐惧,认知失真和适应不良行为模式的测量与主观报告的睡眠破坏有关,p's <.05,但与客观测量的睡眠破坏无关。进一步检查发现,认知和行为因素是主观上报告的睡眠破坏的最大独特方差。结论:本研究的结果表明,许多HSCT接受者在移植后的生存期内继续经历睡眠破坏。癌症特异性因素,关于睡眠的功能障碍认知以及适应不良的睡眠行为与自我报告的睡眠中断有关,并且是认知行为干预的成熟目标。

著录项

  • 作者

    Nelson, Ashley M.;

  • 作者单位

    University of South Florida.;

  • 授予单位 University of South Florida.;
  • 学科 Clinical psychology.
  • 学位 M.A.
  • 年度 2016
  • 页码 51 p.
  • 总页数 51
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号